🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
This study will answer two separate questions. The first question is to te...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-05
Trial ID
NCT00879970
Treatments Being Tested
This is a 24 week study comparing the efficacy of four dose levels of INT13...
Status
Completed
Location
Northern California Research
Start Date
2008-02
Trial ID
NCT00631007
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
The purpose of this study is to evaluate whether 30 mg of pioglitazone admi...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01115712
Treatments Being Tested
This is a multi-centre, multi-national, double-blinded, placebo-controlled,...
Status
Unknown
Location
Universitätsklinik für Innere Medizin
Start Date
2022-05-24
Trial ID
NCT05394142
Treatments Being Tested
Non Alcoholic Fatty Liver Disease (NAFLD) is considered as the component of...
Status
Unknown
Location
Command Hospital
Start Date
2014-10
Trial ID
NCT02265276
Treatments Being Tested
To test the hypothesis that PPAR-gamma agonist, rosiglitazone, induces caro...
Status
Completed
Location
Queen Mary Hospital and Tung Wah Hospital
Start Date
2008-09
Trial ID
NCT00745914
Treatments Being Tested
Type 2 diabetes mellitus is a metabolic disorder that is primarily characte...
Status
Completed
Location
Multi-center
Start Date
2007-07
Trial ID
NCT00515632
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01230749
Treatments Being Tested